205 related articles for article (PubMed ID: 36340711)
21. Imaging in children with ataxia-telangiectasia-The radiologist's approach.
Jończyk-Potoczna K; Potoczny J; Szczawińska-Popłonyk A
Front Pediatr; 2022; 10():988645. PubMed ID: 36186632
[TBL] [Abstract][Full Text] [Related]
22. Genetic Analysis of Patients with Two Different Types of Hyper IgM Syndrome.
Alizadeh Z; Mazinani M; Houshmand M; Shakerian L; Nourizadeh M; Pourpak Z; Fazlollahi MR
Immunol Invest; 2018 Oct; 47(7):745-753. PubMed ID: 30081731
[TBL] [Abstract][Full Text] [Related]
23. Respiratory Complications in Patients with Hyper IgM Syndrome.
Moazzami B; Yazdani R; Azizi G; Kiaei F; Tafakori M; Modaresi M; Shirzadi R; Mahdaviani SA; Sohani M; Abolhassani H; Aghamohammadi A
J Clin Immunol; 2019 Aug; 39(6):557-568. PubMed ID: 31183658
[TBL] [Abstract][Full Text] [Related]
24. [Ataxia telangiectasia and characterization of its immunological disorders].
Matsumoto S; Sakiyama Y; Kajii N; Okano M; Ishizaka A; Ariga T
No To Hattatsu; 1990 Mar; 22(2):103-11. PubMed ID: 2158803
[TBL] [Abstract][Full Text] [Related]
25. Hyper-IgM and acquired C1q complement deficiency in a patient with
Lee AYS; Dai P; Burnett L; Wei X; Kakar F; Ohnesorg T; Lin MW
Oxf Med Case Reports; 2023 Feb; 2023(2):omad005. PubMed ID: 36860961
[TBL] [Abstract][Full Text] [Related]
26. Hyper IgM Syndrome: a Report from the USIDNET Registry.
Leven EA; Maffucci P; Ochs HD; Scholl PR; Buckley RH; Fuleihan RL; Geha RS; Cunningham CK; Bonilla FA; Conley ME; Ferdman RM; Hernandez-Trujillo V; Puck JM; Sullivan K; Secord EA; Ramesh M; Cunningham-Rundles C
J Clin Immunol; 2016 Jul; 36(5):490-501. PubMed ID: 27189378
[TBL] [Abstract][Full Text] [Related]
27. Primary immunodeficiency disease: a retrospective study of 112 Chinese children in a single tertiary care center.
Wu J; Zhong W; Yin Y; Zhang H
BMC Pediatr; 2019 Nov; 19(1):410. PubMed ID: 31684895
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
Joncas JH; Wills A; Reece E; Fox Z
Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
[TBL] [Abstract][Full Text] [Related]
29. Ataxia-telangiectasia: Immunodeficiency and survival.
van Os NJH; Jansen AFM; van Deuren M; Haraldsson A; van Driel NTM; Etzioni A; van der Flier M; Haaxma CA; Morio T; Rawat A; Schoenaker MHD; Soresina A; Taylor AMR; van de Warrenburg BPC; Weemaes CMR; Roeleveld N; Willemsen MAAP
Clin Immunol; 2017 May; 178():45-55. PubMed ID: 28126470
[TBL] [Abstract][Full Text] [Related]
30. The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management.
Yazdani R; Fekrvand S; Shahkarami S; Azizi G; Moazzami B; Abolhassani H; Aghamohammadi A
Clin Immunol; 2019 Jan; 198():19-30. PubMed ID: 30439505
[TBL] [Abstract][Full Text] [Related]
31. Transient increased immunoglobulin levels in a hyper-IgM syndrome patient with COVID-19 infection.
Safarirad M; Ganji AA; Nazari F; Yazdani R; Abolhassani H; Motlagh AV
Allergol Immunopathol (Madr); 2021; 49(6):63-66. PubMed ID: 34761659
[TBL] [Abstract][Full Text] [Related]
32. First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes.
Cabral-Marques O; Klaver S; Schimke LF; Ascendino ÉH; Khan TA; Pereira PV; Falcai A; Vargas-Hernández A; Santos-Argumedo L; Bezrodnik L; Moreira I; Seminario G; Di Giovanni D; Raccio AG; Porras O; Weber CW; Ferreira JF; Tavares FS; de Carvalho E; Valente CF; Kuntze G; Galicchio M; King A; Rosário-Filho NA; Grota MB; dos Santos Vilela MM; Di Gesu RS; Lima S; de Souza Moura L; Talesnik E; Mansour E; Roxo-Junior P; Aldave JC; Goudouris E; Pinto-Mariz F; Berrón-Ruiz L; Staines-Boone T; Calderón WO; del Carmen Zarate-Hernández M; Grumach AS; Sorensen R; Durandy A; Torgerson TR; Carvalho BT; Espinosa-Rosales F; Ochs HD; Condino-Neto A
J Clin Immunol; 2014 Feb; 34(2):146-56. PubMed ID: 24402618
[TBL] [Abstract][Full Text] [Related]
33. Pitfalls of "hyper"-IgM syndrome: a new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature.
Heinold A; Hanebeck B; Daniel V; Heyder J; Tran TH; Döhler B; Greil J; Müller FM
Infection; 2010 Dec; 38(6):491-6. PubMed ID: 20981468
[TBL] [Abstract][Full Text] [Related]
34. Clinical Manifestations, Immunological Characteristics and Genetic Analysis of Patients with Hyper-Immunoglobulin M Syndrome in Iran.
Tafakori Delbari M; Cheraghi T; Yazdani R; Fekrvand S; Delavari S; Azizi G; Chavoshzadeh Z; Mahdaviani SA; Ahanchian H; Khoshkhui M; Behmanesh F; Aleyasin S; Esmaeilzadeh H; Jabbari-Azad F; Fallahpour M; Zamani M; Madani SP; Moazzami B; Habibi S; Rezaei A; Lotfalikhani A; Movahed M; Shariat M; Kalantari A; Babaei D; Darabi M; Parvaneh N; Rezaei N; Abolhassani H; Aghamohammadi A
Int Arch Allergy Immunol; 2019; 180(1):52-63. PubMed ID: 31117086
[TBL] [Abstract][Full Text] [Related]
35. Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs).
Lee WI; Huang JL; Yeh KW; Jaing TH; Lin TY; Huang YC; Chiu CH
J Formos Med Assoc; 2011 Dec; 110(12):750-8. PubMed ID: 22248828
[TBL] [Abstract][Full Text] [Related]
36. Dendritic cells from X-linked hyper-IgM patients present impaired responses to Candida albicans and Paracoccidioides brasiliensis.
Cabral-Marques O; Arslanian C; Ramos RN; Morato M; Schimke L; Soeiro Pereira PV; Jancar S; Ferreira JF; Weber CW; Kuntze G; Rosario-Filho NA; Costa Carvalho BT; Bergami-Santos PC; Hackett MJ; Ochs HD; Torgerson TR; Barbuto JA; Condino-Neto A
J Allergy Clin Immunol; 2012 Mar; 129(3):778-86. PubMed ID: 22154528
[TBL] [Abstract][Full Text] [Related]
37. Primary Antibody Deficiency in a Tertiary Referral Hospital: A 30-Year Experiment.
Mohammadinejad P; Pourhamdi S; Abolhassani H; Mirminachi B; Havaei A; Masoom SN; Sadeghi B; Ghajar A; Afarideh M; Parvaneh N; Mirsaeed-Ghazi B; Movahedi M; Gharagozlou M; Chavoushzadeh Z; Mahdaviani A; Zandieh F; Sherkat R; Sadeghi-Shabestari M; Faridhosseini R; Jabbari-Azad F; Ahanchian H; Zandkarimi M; Cherghi T; Fayezi A; Mohammadzadeh I; Amin R; Aleyasin S; Moghtaderi M; Ghaffari J; Bemanian M; Shafiei A; Kalantari N; Ahmadiafshar A; Khazaei HA; Mohammadi J; Nabavi M; Rezaei N; Aghamohammadi A
J Investig Allergol Clin Immunol; 2015; 25(6):416-25. PubMed ID: 26817138
[TBL] [Abstract][Full Text] [Related]
38. Simple Measurement of IgA Predicts Immunity and Mortality in Ataxia-Telangiectasia.
Zielen S; Duecker RP; Woelke S; Donath H; Bakhtiar S; Buecker A; Kreyenberg H; Huenecke S; Bader P; Mahlaoui N; Ehl S; El-Helou SM; Pietrucha B; Plebani A; van der Flier M; van Aerde K; Kilic SS; Reda SM; Kostyuchenko L; McDermott E; Galal N; Pignata C; Pérez JLS; Laws HJ; Niehues T; Kutukculer N; Seidel MG; Marques L; Ciznar P; Edgar JDM; Soler-Palacín P; von Bernuth H; Krueger R; Meyts I; Baumann U; Kanariou M; Grimbacher B; Hauck F; Graf D; Granado LIG; Prader S; Reisli I; Slatter M; Rodríguez-Gallego C; Arkwright PD; Bethune C; Deripapa E; Sharapova SO; Lehmberg K; Davies EG; Schuetz C; Kindle G; Schubert R
J Clin Immunol; 2021 Nov; 41(8):1878-1892. PubMed ID: 34477998
[TBL] [Abstract][Full Text] [Related]
39. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer.
Subauste CS; Wessendarp M; Sorensen RU; Leiva LE
J Immunol; 1999 Jun; 162(11):6690-700. PubMed ID: 10352287
[TBL] [Abstract][Full Text] [Related]
40. [Unrelated umbilical cord blood stem cell transplantation in the treatment of hyper-IgM syndrome caused by CD40 ligand gene mutation: a report of three cases and literature review].
Wang P; Qian XW; Wang HS; Jiang WJ; Sun JQ; Wang XC; Zhai XW
Zhonghua Er Ke Za Zhi; 2021 Oct; 59(10):830-835. PubMed ID: 34587678
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
